90 results
Page 2 of 5
8-K
EX-99.1
r8p 39reue
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
n25n9n8z zt
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
EX-10.1
1uaiu4vgpb1
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
7nerj 668mpsgmbq6dxw
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
x5ihov8nqk940
20 Dec 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
y0l7s1b 1oyd
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
20ku8q02i0xn2
28 Apr 22
Prospectus supplement for primary offering
8:09am